<DOC>
	<DOCNO>NCT01073007</DOCNO>
	<brief_summary>The purpose study determine whether simvastatin treatment start within first 12 hour stroke onset improves neurological functional outcome , evaluate seventh day/discharge third month . Also , demonstrate simvastatin safe associate high rate hemorrhagic transformation patient receive thrombolysis .</brief_summary>
	<brief_title>Stroke Treatment With Acute Reperfusion Simvastatin</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients older 18 year acute ischemic stroke ( le 12 hour stroke onset ) . Stroke involve MCAACAPCA . NIHSS score 4 22 . Previous modify Rankin Scale score 1 0 . Patient proxy inform consent . Patients take statin past six month . Pregnancy breastfeed . Clinical radiological evidence admission intracranial hemorrhage , hemorrhagic infarction tumor . Seizures time inclusion . Complete substantial recovery prior randomization . Patients ipsilateral neurological deficit may mask evaluation current event . Liver disease ( AST ALT twice upper normality limit ) . Cardiogenic shock relevant cardiac failure . Patients five time upper normality limit CPK . Myocardial infarction thromboembolic event within previous 30 day . Active infection time inclusion . Documented hypersensibility statin . Drug abuse . Expected short lifeexpectancy relate systemic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Acute Stroke</keyword>
	<keyword>tissue plasminogen activator</keyword>
	<keyword>simvastatin</keyword>
</DOC>